PlainRecalls

F.h. Investments, Inc. (dba Asteria Health)

25 recalls on record · Latest: Feb 18, 2026

Subscribe to new F.h. Investments, Inc. recalls (RSS)

Agency notice ledger

Federal filing book F.h. Investments, Inc. MID-BOOK · SINGLE-AGENCY

#645 of 14,151 · 25 notices · 0.024% archive

  • BOOK 25 notices
  • RANK #645 of 14,151
  • SHARE 0.024% archive
  • AGENCY FDA Drug (25)
  • CAT drugs
  • CATS 1 category
  • LATEST Feb 18, 2026
  • PHOTO Asp Global, LLC. dba…

Nearest notice-volume peer: Asp Global, LLC. dba Anatomy Supply Partners, LLC. (0 notice gap)

F.h. Investments, Inc. (dba Asteria Health) accounts for about 0.024% of the 104,423-notice archive on 25 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where F.h. Investments, Inc. sits among 14,151 recalling firms

F.h. Investments, Inc. (dba Asteria Health) ranks 645th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

F.h. Investments, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

25 645th of 14151 higher than 13,484 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

F.h. Investments, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows F.h. Investments, Inc. (dba Asteria Health) holds about 0.024% of archive notices alongside 25 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Feb 18, 2026

Testosterone, 100 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-1100-32.

FDA Drug Moderate Feb 18, 2026

Testosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.

FDA Drug Moderate Feb 18, 2026

Testosterone, 25.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1025-32.

FDA Drug Moderate Feb 18, 2026

ESTRADIOL, 25 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3025-32.

FDA Drug Moderate Feb 18, 2026

Testosterone, 87.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1087-32.

FDA Drug Moderate Feb 18, 2026

ESTRADIOL, 10 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3010-32.

FDA Drug Moderate Feb 18, 2026

Testosterone 200mg, Triamcinolone Acetonide 40mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-6200-43.

FDA Drug Moderate Feb 18, 2026

ESTRADIOL, 20 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3020-32.

FDA Drug Moderate Feb 18, 2026

Testosterone, 62.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1062-32.

FDA Drug Moderate Feb 18, 2026

Testosterone, 12.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1012-32.

FDA Drug Moderate Feb 18, 2026

Testosterone 100mg, Anastrozole 4mg (4.5), 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-01.

FDA Drug Moderate Feb 18, 2026

Testosterone, 303 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1303-01.

FDA Drug Moderate Feb 18, 2026

Testosterone 100mg, Triamcinolone Acetonide 20mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-6100-32.

FDA Drug Moderate Feb 18, 2026

ESTRADIOL, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3037-32.

FDA Drug Moderate Feb 18, 2026

ESTRADIOL, 12.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79599-3012-32.

FDA Drug Moderate Feb 18, 2026

Testosterone, 18.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1018-32.

FDA Drug Moderate Feb 18, 2026

ESTRADIOL,15 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3015-32.

FDA Drug Moderate Feb 18, 2026

Testosterone, 50.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1050-32.

FDA Drug Moderate Feb 18, 2026

Testosterone, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1037-32.

FDA Drug Moderate Feb 18, 2026

ESTRADIOL, 18 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 3521, NDC: 79559-3018-32.

FDA Drug Moderate Feb 18, 2026

Testosterone 87.5mg, Triamcinolone Acetonide17.5 mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-6087-32.

FDA Drug Moderate Feb 18, 2026

ESTRADIOL, 22 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3022-32.

FDA Drug Moderate Feb 18, 2026

Testosterone 100mg Anastrozole 4mg , 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-32

FDA Drug Moderate Feb 18, 2026

Testosterone 75mg, Anastrozole 4mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4079-32.

FDA Drug Moderate Feb 18, 2026

ESTRADIOL, 6 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3006-32.

F.h. Investments, Inc. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name F.h. Investments, Inc.?
PlainRecalls indexes 25 distinct federal recall events naming F.h. Investments, Inc. (dba Asteria Health), aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does F.h. Investments, Inc. sit among other recalling firms?
F.h. Investments, Inc. (dba Asteria Health) ranks #645 of 14,151 by distinct recall-event count among 14,151 firms in this archive (95th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of F.h. Investments, Inc.'s notices?
FDA Drug accounts for 25 of this firm's 25 indexed notices.
What product category dominates F.h. Investments, Inc.'s filing book?
Filings for F.h. Investments, Inc. (dba Asteria Health) span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous?
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
F.h. Investments, Inc. (dba Asteria Health): 25 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming F.h. Investments, Inc. (dba Asteria Health); individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026